Bone Biologics Corporation (BBLG)
NASDAQ · Healthcare
Bone Biologics Corporation Shareholder Equity 2019–2020
Bone Biologics Corporation annual/quarterly shareholder equity history from 2019 to 2020. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bone Biologics Corporation shareholder equity for the quarter ending December 31, 2020 were -13.7M, a 15.38% increase year-over-year.
- Bone Biologics Corporation shareholder equity for 2020 were -13.7M, a 15.38% increase from 2019.
- Bone Biologics Corporation shareholder equity for 2019 were -11.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bone Biologics Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2020 | $-14 |
| 2019 | $-12 |
| Bone Biologics Corporation Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2020-12-31 | $-14 |
| 2019-12-31 | $-12 |
Bone Biologics Corporation Shareholder Equity — FAQ
Bone Biologics Corporation (BBLG) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBLG's shareholder equity history?
The chart and table above show Bone Biologics Corporation's shareholder equity by year and by quarter, including the growth rate.